Athersys Inc logo

Athersys Inc

$ 1.63 0 (0%) 08:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 469.87M
Enterprise V:
$ 493.21M
Volume:
560.15K
Avg Vol (2M):
1.84M
Also Trade In:
Volume:
560.15K
Market Cap $:
469.87M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.84M
Enterprise Value $:
493.21M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.
Name Current Vs Industry Vs History
Cash-To-Debt 1.44
Equity-to-Asset -0.33
Debt-to-Equity -0.79
Debt-to-EBITDA -0.11
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -26.62
Distress
Grey
Safe
Beneish M-Score 6.47
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 49.34
9-Day RSI 37.84
14-Day RSI 34.32
6-1 Month Momentum % -80.35
12-1 Month Momentum % -90.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.64
Quick Ratio 0.64
Cash Ratio 0.4
Days Sales Outstanding 68.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.9

Financials (Next Earnings Date:2022-11-15 Est.)

ATHX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ATHX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10.742
EPS (TTM) ($) -0.34
Beta -1.82
Volatility % 77.31
14-Day RSI 34.32
14-Day ATR ($) 0.438354
20-Day SMA ($) 2.0295
12-1 Month Momentum % -90.88
52-Week Range ($) 1.13 - 35.5
Shares Outstanding (Mil) 305.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Athersys Inc Filings

Document Form Filing Date
No Filing Data

Athersys Inc Analysis

Share your research

Headlines

See More
No news.